PCOS does not mean you cannot get pregnant: it is the most common cause of anovulatory infertility — accounting for roughly 50% of women who present with infertility — and first-line letrozole produced a cumulative live-birth rate of 27.5% over up to five cycles versus 19.1% with clomiphene. The usual order is lifestyle and ovulation induction first, IUI second, IVF third, and most people never need step three.
This guide is based on randomized trials and Cochrane meta-analyses of ovulation induction in PCOS: Legro et al. (NEJM 2014), Franik et al. (Cochrane 2022), Morley et al. (Cochrane 2017), and Wang et al. (2019). It also draws on the international PCOS guideline and WHO infertility estimates, and was compiled by the ProIVF medical editing team and reviewed by the ProIVF medical advisory board.
Can you get pregnant naturally with PCOS?
Often yes, and usually sooner than people expect. PCOS affects an estimated 8%–13% of reproductive-age women and is responsible for about half of anovulatory infertility (infertility from absent or irregular ovulation), but anovulation is one of the most treatable causes of infertility — restoring regular ovulation is frequently enough for conception without IVF.
“Despite affecting ~11-13% of women globally, polycystic ovary syndrome (PCOS) is a substantially understudied condition.” — Stener-Victorin et al., Nature Reviews Disease Primers, 2024
What “treatable” means in practice is worth spelling out, because it changes what you ask for. The mechanism is hormonal rather than structural: the ovaries are usually full of usable follicles, but the hormonal pattern of PCOS prevents one of them from being selected and released. Fix the selection signal and many women ovulate within weeks.
Why does PCOS stop ovulation?
Three overlapping mechanisms explain it: insulin resistance drives the ovaries to produce more androgen, excess androgen interferes with follicle selection, and the resulting hormone pattern keeps the brain from sending the surge that releases an egg. That is why the same three treatments keep reappearing — improve insulin sensitivity (metformin, weight loss), lower androgen effect (letrozole), or bypass selection entirely (gonadotropins, IVF).
The label itself matters less than the phenotype. Diagnosis requires two of three features: clinical or biochemical hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology or elevated anti-Müllerian hormone. Two women with the same “PCOS” label can therefore respond very differently to the same drug.
Which drug works best for ovulation induction in PCOS?
Letrozole is now the usual first choice, and the evidence is the strongest in this whole field: in a 750-woman randomized trial it produced a cumulative live-birth rate of 27.5% (103 of 374) versus 19.1% (72 of 376) for clomiphene over up to five cycles (rate ratio 1.44). It also gave a higher cumulative ovulation rate (61.7% vs. 48.3%) and fewer twin pregnancies (3.4% vs. 7.4%) — Legro et al., New England Journal of Medicine, 2014.
“As compared with clomiphene, letrozole was associated with higher live-birth and ovulation rates among infertile women with the polycystic ovary syndrome.” — Legro et al., New England Journal of Medicine, 2014
Meta-analysis reaches the same conclusion with more power. Across randomized trials, letrozole improved live birth over clomiphene-type drugs (odds ratio 1.72, high-certainty evidence) with a number needed to treat of about 10. Miscarriage per pregnancy (24% vs. 25%), multiple pregnancy (1.6% vs. 2.2%) and OHSS (ovarian hyperstimulation syndrome) (0.5% in both arms) were all unchanged — Franik et al., Cochrane Database, 2022.
| Outcome over up to 5 cycles | Letrozole | Clomiphene |
|---|---|---|
| Cumulative live birth | 27.5% | 19.1% |
| Cumulative ovulation | 61.7% | 48.3% |
| Twin pregnancy | 3.4% | 7.4% |
| Pregnancy loss (per pregnancy) | 31.8% | 29.1% |
Two reassurances worth knowing if letrozole has been recommended to you. An individual-participant-data meta-analysis confirmed the live-birth advantage (rate ratio 1.43 across 1,043 women), and a systematic review of fetal outcomes found congenital anomalies in 2.15% of letrozole exposures with no significant excess over clomiphene. We cover both drugs in detail in our letrozole guide and clomiphene guide.
Does metformin help you get pregnant with PCOS?
Modestly, and mostly as an addition rather than a replacement. Compared with placebo, metformin improved ovulation (odds ratio 2.55), clinical pregnancy (1.93) and live birth (1.59, low-certainty evidence), but it also caused gastrointestinal side effects more than four times as often (odds ratio 4.76) — Morley et al., Cochrane Database, 2017.
Where metformin clearly earns its place is as an add-on. Combined with gonadotropins it roughly doubled live birth in a Cochrane analysis (odds ratio 2.31, low-certainty evidence). Used before and during IVF, it cut the incidence of OHSS from about 20% to 6%–14% (risk ratio 0.46). If your cycle is irregular rather than absent, or if you are heading into stimulation with a high follicle count, metformin is usually doing metabolic work rather than ovulation work.
How much does weight loss actually move the needle?
More than most drugs, in the subgroup where it applies: a loss of 5%–10% of body weight in women with PCOS and a raised BMI is the standard target because it can restore spontaneous ovulation, improve insulin sensitivity, and reduce OHSS risk and stimulation difficulty later. For the cycle-level detail, see our BMI and IVF guide.
- It is the only intervention on this list that also improves pregnancy outcomes, not just conception rates.
- It is also the hardest to do in a compressed treatment timeline, which is why many clinics pair a structured program with a planned start date rather than waiting for a target weight.
Neither point is an argument to delay treatment indefinitely: in women with a normal BMI, weight loss is not part of the plan, and age itself is a stronger predictor of outcome than any lifestyle factor.
When should you move from ovulation induction to IUI or IVF?
The conventional ladder is three to six ovulation-induction cycles, then IUI, then IVF — and it exists because each rung multiplies cost and multiple-pregnancy risk, not because success is guaranteed by moving up. A reasonable rule of thumb after 3–6 ovulatory letrozole cycles without conception is to escalate rather than repeat the same protocol.
Three situations justify skipping rungs:
- Tubal or male factor is present, because ovulation induction cannot fix a blocked tube or low sperm count.
- Age over 38, where the time cost of failed induction cycles outweighs their lower price.
- Repeated hyper-response or OHSS risk, where stimulation management in an IVF setting is safer than repeating gonadotropin cycles.
IUI adds sperm preparation and timed placement on top of ovulation induction; our IUI procedure guide and IUI versus IVF success rates compare the two directly.
Is IVF different when you have PCOS?
Yes, in both directions. A meta-analysis of IVF outcomes in PCOS found women produced more oocytes per cycle (+3.67) and more mature oocytes (+2.16) at a lower gonadotropin dose (−361.3 IU) than controls — but also had a higher risk of OHSS (odds ratio 3.58) and miscarriage (1.44), with a lower fertilization rate (0.79) — Tang et al., 2021.
That combination is why PCOS protocols look different rather than worse. Antagonist protocols, low-dose gonadotropin starts, GnRH-agonist triggers instead of hCG, and freeze-all strategies all exist to convert a high follicle count into a safe cycle rather than a canceled or complicated one. Metformin before and during stimulation is part of that toolbox (OHSS risk ratio 0.46). For the full IVF-specific playbook, see our PCOS IVF guide.
Does PCOS increase miscarriage risk?
Modestly, and the reason matters more than the number: in IVF pregnancies PCOS carried a miscarriage odds ratio of 1.44 compared with controls, and loss rates in ovulation-induction trials ran around 29%–32% of pregnancies in both treatment arms. Those figures overlap heavily with the effect of raised BMI, which is itself a miscarriage risk factor.
The reassuring part is that the treatments above do not add risk. Miscarriage per pregnancy was 24% with letrozole versus 25% with clomiphene in high-certainty Cochrane data, and congenital anomaly rates did not differ between the two drugs.
Three patients, three different PCOS routes
The patient stories below are shared with consent. Names and identifying details have been changed to protect privacy.
Amina, 28 — Lagos, Nigeria
Amina’s cycles came every 45–90 days. Her BMI was 31, and instead of starting drugs her clinic gave her a 6-month structured program that cost about 350 USD; she lost 9 kg (11% of body weight) and ovulated on her own in the fourth month, conceiving without medication in the sixth.
“I thought PCOS meant IVF. Nobody told me the first prescription would be a walking plan and a food log. I was furious for a month, and then my period came by itself for the first time in two years,” she said.
Mei-Ling, 33 — Taipei, Taiwan, China
Mei-Ling had three failed clomiphene cycles before switching to letrozole plus metformin; she ovulated in 61 of 90 days on the new protocol and conceived in her second letrozole cycle (about 900 USD in total medication). The pregnancy ended in a miscarriage at 9 weeks, and her second letrozole pregnancy is now 32 weeks.
“Changing the drug felt like giving up on the cheap route. It was the opposite — I spent more months and more money on the wrong drug than the right one would have cost,” she said.
Olga, 39 — Prague, Czech Republic
Olga went straight to IVF after four anovulatory years, because at 39 she did not want to spend a year on induction. Her PCOS protocol produced 24 oocytes at a low gonadotropin dose, ended in a freeze-all after mild OHSS symptoms, and her first frozen transfer (about 6,800 USD) resulted in a live birth at 38 weeks.
“Twenty-four eggs sounds like winning, and for two weeks it was scary instead — I was full of fluid and my clinic was watching me daily. PCOS gave me quantity and then made quantity the problem,” she recalled.
FAQ
Q: How long does it take to get pregnant with PCOS?
With letrozole ovulation induction, trials measured cumulative live birth over up to 5 cycles, reaching 27.5%; most conceptions that occur on induction happen in the first three ovulatory cycles.
Q: Is letrozole safer than clomiphene?
ACOG patient guidance on PCOS treats ovulation induction as a standard, monitored treatment rather than a last resort.
Neither drug showed a safety difference that would decide the choice: congenital anomalies were 2.15% with letrozole and not significantly different from clomiphene, while miscarriage per pregnancy was 24% versus 25%. Letrozole’s real advantages are live birth (odds ratio 1.72) and fewer twins (1.6% vs. 2.2%).
Q: Should I take metformin if I am already ovulating?
Usually not on its own. Metformin improved live birth over placebo (odds ratio 1.59) but with low-certainty evidence and 4.76 times more gastrointestinal side effects, so it earns its place for insulin resistance, irregular rather than absent cycles, or OHSS prevention rather than as a stand-alone fertility drug.
Q: Can I have PCOS and regular periods?
Yes. Diagnosis requires 2 of 3 criteria, so regular cycles do not rule it out: hyperandrogenism plus polycystic ovarian morphology or elevated AMH is enough, and PCOS affects 8%-13% of reproductive-age women across a wide range of cycle patterns.
Q: Does PCOS affect egg quality?
The main effect is on quantity and selection rather than quality per se: PCOS women produced 3.67 more oocytes per IVF cycle but had a lower fertilization rate (odds ratio 0.79) and higher miscarriage odds (1.44), part of which is explained by coexisting insulin resistance and raised BMI.
Q: Is IVF the best option if I have PCOS?
WHO estimates that one in six people worldwide experience infertility in their lifetime, and anovulatory infertility is among the most treatable forms.
Usually not first. Ovulation induction is cheaper, less invasive, and reached 27.5% cumulative live birth in trials; IVF earns its place after 3–6 failed ovulatory cycles, with tubal or male factor, at advanced age, or when OHSS risk makes supervised stimulation the safer route.
Q: Does losing weight guarantee ovulation with PCOS?
No guarantee, but it is the highest-yield single change in women with a raised BMI: a 5%–10% reduction can restore spontaneous ovulation, and it is the only intervention that also improves pregnancy outcomes rather than just conception rates.
Q: Can PCOS come back after pregnancy?
The hormonal pattern persists — prevalence stays in the 8%-13% range across reproductive life — so cycle irregularity often returns after weaning, and what matters afterwards is blood-sugar and cardiovascular screening, not more fertility treatment.
How to plan your next steps
PCOS is a sequencing problem more than a prognosis problem: the drug order, the number of cycles, and the timing of escalation decide most outcomes. If your treatment has stalled at one rung for more than six months, that is the moment to ask whether the plan — not your body — is the thing that needs to change.
You can compare vetted fertility centers in our hospital directory, read how we evaluate IVF clinics, or contact our advisors for a free review of your cycle history before you commit to another round.
Medical disclaimer: This article is for general information only and is not medical advice. Ovulation-induction drugs require prescription and monitoring. Please consult a qualified reproductive endocrinologist before starting, stopping, or changing any medication.
How this article was created: This article was written by the ProIVF medical editing team based on randomized trials and Cochrane systematic reviews of ovulation induction in PCOS, the international PCOS guideline, and WHO infertility estimates, and was reviewed by the ProIVF medical advisory board. It is intended to help patients make informed decisions and is not influenced by any clinic or commercial relationship; institutions named in patient stories are not affiliated with ProIVF.
Last updated: october 08, 2026
